about
Life-threatening hyperkalemia from cream of tartar ingestionNeurologic manifestations of chronic methamphetamine abuseHIV-1 gp120-induced neurotoxicity to midbrain dopamine culturesAbsinthe: return of the Green Fairy.Orexinergic neurotransmission in temperature responses to methamphetamine and stress: mathematical modeling as a data assimilation approach.Hyperbaric oxygen therapy in acute ischemic stroke: results of the Hyperbaric Oxygen in Acute Ischemic Stroke Trial Pilot Study.19F nuclear magnetic resonance analysis of trifluoroethanol metabolites in the urine of the Sprague-Dawley rat.Toxin-induced hyperthermic syndromes.Heavy metal poisoning: clinical presentations and pathophysiology.Availability of mobile phones for discharge follow-up of pediatric Emergency Department patients in western KenyaTreadmill running restores MDMA-mediated hyperthermia prevented by inhibition of the dorsomedial hypothalamus.Acute Methylenedioxypyrovalerone Toxicity.The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine.Historical neurotoxins: what we have learned from toxins of the past about diseases of the present.Cerebrovascular and cardiovascular complications of alcohol and sympathomimetic drug abuse.Exercise activates compensatory thermoregulatory reaction in rats: a modeling study.Hyperthermic syndromes induced by toxins.Yohimbine is a 5-HT1A agonist in rats in doses exceeding 1 mg/kg.Temperature in the spotlight of drug abuse research.When administered to rats in a cold environment, 3,4-methylenedioxymethamphetamine reduces brown adipose tissue thermogenesis and increases tail blood flow: effects of pretreatment with 5-HT1A and dopamine D2 antagonists.Microinjection of muscimol into the dorsomedial hypothalamus suppresses MDMA-evoked sympathetic and behavioral responses.Neurologic manifestations of chronic methamphetamine abuse.The Ergogenic Effect of Amphetamine.Inhibition of the dorsomedial hypothalamus, but not the medullary raphe pallidus, decreases hyperthermia and mortality from MDMA given in a warm environment.Synthetic cathinones ("bath salts").Faculty Mentoring Practices in Academic Emergency Medicine.Police Officers Can Safely and Effectively Administer Intranasal Naloxone.The role of orexin-1 receptors in physiologic responses evoked by microinjection of PgE2 or muscimol into the medial preoptic area.Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced rhabdomyolysis with alpha1- plus beta3-adrenoreceptor antagonists.Amphetamine enhances endurance by increasing heat dissipation.On-site treatment of exertional heat stroke.Brief Toxicology Observation: What Kind of Burger Did This Patient Eat?Qualitative study of healthcare providers' current practice patterns and barriers to successful rehydration for pediatric diarrheal illnesses in Kenya.Hard impact: journal impact factor and JMT.Pearls and pitfalls in the approach to patients with neurotoxic syndromes.Thallium and arsenic poisoning in a small midwestern town.Estimating the weight of children in Kenya: do the Broselow tape and age-based formulas measure up?Increased adolescent opioid use and complications reported to a poison control center following the 2000 JCAHO pain initiative.Dimercaptosuccinic acid and Prussian Blue in the treatment of acute thallium poisoning in rats.A prospective, randomized, double-blind comparison of buffered versus plain tetracaine in reducing the pain of topical ophthalmic anesthesia.
P50
Q24621407-8729E798-CD73-406B-BF8A-FF86557A6D79Q24624506-49D39167-E924-40FB-96CC-099703A38275Q28290856-1448B1EB-DDED-4882-B9B3-7B2410C4975FQ30309815-D301B446-1FBF-464B-A472-7A420C1AA397Q30955456-28C6AA88-FB25-4410-8DB4-82FC3B4190B5Q33426461-ECA35905-B115-4DA4-B993-BD9927DF89B5Q33479185-0176A6ED-EACD-464D-89B8-6534C91BF2EBQ34459874-4CD364C1-5D66-47E4-AE20-305605B6916CQ34505931-D59F93E4-2DC1-457C-8C69-52BAEC9F7D06Q35174041-45BD47A1-A8DB-4B3A-92F1-22C498E7173CQ35306109-0004FB63-9512-457B-B56A-61D813CF1C74Q35749136-118BA8A6-FD36-4A2D-A7A6-72227CED164CQ35986088-4F2C92BE-8249-4EEC-A4BB-83BB8AD561B0Q36066386-396FD0D2-BA80-4437-9BDA-65B7B99A9A8CQ36287449-BF8D068A-36F2-4922-BAB5-6619830A9D42Q36382237-208AC237-71B0-4C03-802B-A50F26CE9B45Q36433130-8C7F3529-0B35-412C-A8EE-60369CC8DD34Q36501331-D64420B0-0CC6-45ED-8F37-9FC7A72A23AFQ36832628-37C8D16D-44E1-40C1-B646-D4C901876E48Q36856179-64CE44B3-C688-46E0-81B4-8E9FFBC4E9B1Q37011117-AD361F29-EB4D-463E-8A45-D6457529EF33Q37150547-0AB16539-F124-4F34-870E-FC454B985DDCQ37210754-FE59A156-5CE4-4F1E-B56F-364D7E215021Q37714504-1689185B-DEF6-4540-BCEE-B9591FF72214Q38190773-56499005-5463-438B-ADFC-945F7FDD7477Q39176853-BBA6556E-25F7-4798-98AA-B0EF91313B81Q39740713-67BA8373-1DB2-4CD2-9CA1-0340D06D914DQ40324430-65A8AE15-F3DC-44B8-8610-E75670D747C8Q40533420-AF27307A-5E6F-42A3-A025-90CD20273423Q41116602-CE2D8027-C858-483E-9A20-88CFFBBEB5FDQ41511067-4B64A496-8476-4CFB-9728-2171ED903163Q41912976-30AEA2D5-C9F1-4D44-964F-DDCFD4B5790FQ42269685-AAF679D3-CDEA-4513-A2E6-3E54681721EFQ42869851-FFB6F9E9-6078-406F-BC02-33239E8883F7Q43843900-6EB674EB-4162-49AF-A2B0-95EA43F63E05Q43898383-2ADBF3A3-066C-4616-AC34-D3320780E40AQ43988634-048C1629-DFE5-4812-9701-576161B3AD75Q44330077-D9459E41-CC46-4543-B121-349F8E116713Q44431734-12CEFF2B-6C44-4FD7-80C6-F626E4655319Q44452137-24FB1BB1-3E6C-4BE1-AEB0-4291F9FF2DF8
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Daniel E Rusyniak
@ast
Daniel E Rusyniak
@en
Daniel E Rusyniak
@es
Daniel E Rusyniak
@fr
Daniel E Rusyniak
@nl
Daniel E Rusyniak
@sl
type
label
Daniel E Rusyniak
@ast
Daniel E Rusyniak
@en
Daniel E Rusyniak
@es
Daniel E Rusyniak
@fr
Daniel E Rusyniak
@nl
Daniel E Rusyniak
@sl
prefLabel
Daniel E Rusyniak
@ast
Daniel E Rusyniak
@en
Daniel E Rusyniak
@es
Daniel E Rusyniak
@fr
Daniel E Rusyniak
@nl
Daniel E Rusyniak
@sl
P106
P21
P31
P496
0000-0002-6199-0840